These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 876316)

  • 21. Congestive cardiomyopathy: therapeutic approach.
    Chatterjee K; Stern L
    Compr Ther; 1982 Jul; 8(7):25-34. PubMed ID: 7116806
    [No Abstract]   [Full Text] [Related]  

  • 22. Therapeutic application of prazosin in chronic refractory congestive heart failure. Tolerance and "tachyphylaxis" in perspective.
    Awan NA; Needham KE; Evenson MK; Amsterdam EE; Mason DT
    Am J Med; 1981 Jul; 71(1):153-60. PubMed ID: 7246573
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of oral prazosin therapy on exercise hemodynamics in patients with severe chronic heart failure.
    Chatterjee K; Rubin SA; Ports TA; Parmley WW
    Am J Med; 1981 Jul; 71(1):140-6. PubMed ID: 7246571
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vasodilator therapy for chronic heart failure.
    Chatterjee K; Parmley WW
    Annu Rev Pharmacol Toxicol; 1980; 20():475-512. PubMed ID: 6770743
    [No Abstract]   [Full Text] [Related]  

  • 25. [The effect of oral prazosin therapy on severe cardiac insufficiency].
    Józan M; Tarján J; Tordasi E; Wágner G; Bordás I; Jávor A; Kovács S
    Orv Hetil; 1983 May; 124(21):1259-61. PubMed ID: 6877803
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of alpha-receptor blockade with prazosin in advanced chronic congestive heart failure.
    Lui HK; Awan NA; Mason DT
    Herz; 1983 Apr; 8(2):65-70. PubMed ID: 6303929
    [No Abstract]   [Full Text] [Related]  

  • 27. [Prazosin in the treatment of chronic resistant heart failure].
    Kleinman Y; Tzivoni D
    Harefuah; 1981 Apr; 100(8):398-401. PubMed ID: 7274816
    [No Abstract]   [Full Text] [Related]  

  • 28. [Chronic administration of prazosin in patients with congestive cardiomyopathy (author's transl)].
    Kuhn H; Boch H; Lösse B
    Z Kardiol; 1981 Jul; 70(7):501-7. PubMed ID: 7269730
    [No Abstract]   [Full Text] [Related]  

  • 29. [Alterations in the sympathetic nervous activity during vasodilator therapy by nitroprusside and prazosin in patients with congestive heart failure (author's transl)].
    Yui Y; Nakajima H; Sakurai K; Wakabayashi A; Kawai C
    Kokyu To Junkan; 1981 Jul; 29(7):723-6. PubMed ID: 7291740
    [No Abstract]   [Full Text] [Related]  

  • 30. Vasodilator therapy of chronic congestive heart failure.
    Cabaniss CD
    J Med Assoc Ga; 1980 Feb; 69(2):131-2. PubMed ID: 7373170
    [No Abstract]   [Full Text] [Related]  

  • 31. Vasodilator therapy of congestive heart failure.
    Cohn JN
    Adv Intern Med; 1980; 26():293-315. PubMed ID: 6784453
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effect of vasodilator treatment of chronic circulatory insufficiency on various polycardiographic parameters].
    Guzińska B; Nartowicz E
    Kardiol Pol; 1983; 26(7):565-70. PubMed ID: 6645153
    [No Abstract]   [Full Text] [Related]  

  • 33. [Hemodynamic effects of prazosin in heart failure].
    Bassand JP; Becque O; Vial Y; Berthout P; Maurat JP
    Nouv Presse Med; 1979 Nov; 8(44):3663. PubMed ID: 534219
    [No Abstract]   [Full Text] [Related]  

  • 34. [Captopril in chronic congestive heart failure--dose-effect behavior and comparison with prazosin].
    Froer KL; Hall D; Rudolph W
    Herz; 1983 Apr; 8(2):81-7. PubMed ID: 6343211
    [No Abstract]   [Full Text] [Related]  

  • 35. [Haemodynamic effects and plasma concentrations of prazosin in chronic heart failure (author's transl)].
    Pornin M; Decourt S; Sellier P; Guermonprez JL; Ourbak P; Maurice P; Flouvat B
    Therapie; 1981; 36(4):435-42. PubMed ID: 7292426
    [No Abstract]   [Full Text] [Related]  

  • 36. [Long-term vasodilator therapy for chronic congestive heart failure: is it effective?].
    Yasuda H; Obata H
    Kokyu To Junkan; 1985 Mar; 33(3):241-5. PubMed ID: 3892610
    [No Abstract]   [Full Text] [Related]  

  • 37. The role of vasodilator therapy in the management of the patient with acute myocardial infarction.
    Wagner GC; Robinson PH
    Prim Care; 1981 Sep; 8(3):467-81. PubMed ID: 6796986
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study.
    Cohn JN; Archibald DG; Ziesche S; Franciosa JA; Harston WE; Tristani FE; Dunkman WB; Jacobs W; Francis GS; Flohr KH
    N Engl J Med; 1986 Jun; 314(24):1547-52. PubMed ID: 3520315
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sustained reduction of cardiac impedance and preload in congestive heart failure with the antihypertensive vasodilator prazosin.
    Miller RR; Awan NA; Maxwell KS; Mason DT
    N Engl J Med; 1977 Aug; 297(6):303-7. PubMed ID: 889599
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Long-term therapy with oral prazosin in chronic congestive heart failure: a clinical and echocardiographic evaluation (author's transl)].
    Sparvieri F; Cesari GP; Soro A
    G Ital Cardiol; 1980; 10(6):730-40. PubMed ID: 6780400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.